The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Unternehmens-codeTOIIW
Name des UnternehmensOncology Institute Inc
IPO-datumMar 13, 2020
Gegründet am2019
CEODr. Daniel Virnich, M.D.
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
Addresse18000 Studebaker Rd
StadtCERRITOS
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl90703
Telefon15627353226
Websitehttps://theoncologyinstitute.com/
Unternehmens-codeTOIIW
IPO-datumMar 13, 2020
Gegründet am2019
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten